Join Qinecsa at DIA Europe 2025
February 18, 2025
Qinecsa is thrilled to be exhibiting at the DIA EU, from March 18-20 2025 in Basel, Switzerland. DIA Europe 2025 will focus on sustainability, innovation
Qinecsa is thrilled to be exhibiting at the DIA EU, from March 18-20 2025 in Basel, Switzerland. DIA Europe 2025 will focus on sustainability, innovation
Industry Insights – Pharmaceutical Technology talks to Qinecsa Solutions‘ CEO, Adam Sherlock about the outlook for the Life Sciences industry in 2025, focusing in on
On The Agenda: Introduction Tackling Compliance and Global Challenges: Key regulatory requirements (e.g. EMA) and best practices – Strategies for addressing global surveillance complexities Next-
Qinecsa is thrilled to be exhibiting at the DIA Global Pharmacovigilance & Risk Management Strategies Conference, from January 27-29 2025 in Baltimore, MD. DIA’s Global
Thought leadership from Martin Holm-Petersen continues! Qinecsa’s Chief Strategy Officer contributes to PharmaVoice’s 2025 AI Trends Feature. In his contribution, Martin highlights how working with
Latest News – We’re pleased to share that our CEO Adam Sherlock has been featured on Pharmaceutical Technology‘s Drug Solutions podcast joining industry experts to
Veteran safety & PV leader Adam Sherlock will capitalize on Qinecsa’s deep domain expertise and comprehensive technology-powered solutions to pharma’s most complex product safety challenges
We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress America 2024! THE LARGEST DRUG SAFETY EVENT IN THE WORLD
Pharmacovigilance is a critical component of the medicinal product lifecycle, focusing on ensuring the safety and efficacy of medicinal products from pre-clinical development through post-marketing
We are thrilled to announce that Qinecsa will be sponsoring the World Drug Safety Congress Europe 2024, marking our third year! EUROPE’S MOST EXCITING DRUG
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274
